Key Takeaways
- • University of Utah and EPIC Ventures launched University of Utah Ventures, Powered by EPIC, combining the university's ~$700 million in annual research funding with EPIC's venture scaling expertise to support early-stage companies in software, healthcare, life sciences, and fintech.
- • EPIC Ventures secured $200 million in fresh capital to deploy through the partnership, targeting founders in healthcare, software, and AI sectors across the region.
- • The partnership leverages a proven track record: U and EPIC previously co-invested in Recursion Pharmaceuticals, which grew to a $2 billion publicly traded company, demonstrating the model's viability for scaling university-backed innovation.
- • The initiative integrates venture capital earlier into the research discovery pipeline as part of the University of Utah's broader strategic plan to improve technology transfer and commercialization processes.
- • Jim Hotaling, associate vice president of research for commercialization, facilitated the partnership through the Utah Venture Hub, the university's designated office for startup support.
Summary
The University of Utah and Salt Lake City–based EPIC Ventures announced a strategic partnership to establish University of Utah Ventures, Powered by EPIC, positioning the collaboration as a model for translating academic research into commercial ventures and regional economic development. The partnership combines the university's extensive research infrastructure—supported by approximately $700 million in annual research funding—with EPIC Ventures' operational expertise and network to accelerate early-stage companies across software, healthcare, life sciences, and financial technology sectors.
EPIC Ventures is deploying $200 million in fresh capital through the fund to support early-stage founders addressing problems in healthcare, software, and artificial intelligence. University of Utah President Taylor Randall characterized the initiative as "transformative," stating that the partnership positions the institution to "foster groundbreaking innovation within our institution but also to drive significant economic growth across the region." The collaboration extends beyond capital deployment; it reflects a strategic shift in how the university integrates commercialization into its research discovery pipeline.
The partnership's credibility rests on demonstrated success. The University of Utah and EPIC previously co-invested in Recursion Pharmaceuticals, a platform company that has grown into a $2 billion publicly traded entity, validating the university-venture capital model. Erin Rothwell, vice president of research at the U, emphasized that the fund represents part of a larger strategic plan to enhance the university's technology transfer process and embed commercialization earlier within research initiatives rather than treating it as an afterthought. The Utah Venture Hub, run by Jim Hotaling in his role as associate vice president of research for commercialization, facilitated the partnership, underscoring the university's institutional commitment to bridging the gap between academic discovery and entrepreneurial execution.
EPIC Ventures is deploying $200 million in fresh capital through the fund to support early-stage founders addressing problems in healthcare, software, and artificial intelligence. University of Utah President Taylor Randall characterized the initiative as "transformative," stating that the partnership positions the institution to "foster groundbreaking innovation within our institution but also to drive significant economic growth across the region." The collaboration extends beyond capital deployment; it reflects a strategic shift in how the university integrates commercialization into its research discovery pipeline.
The partnership's credibility rests on demonstrated success. The University of Utah and EPIC previously co-invested in Recursion Pharmaceuticals, a platform company that has grown into a $2 billion publicly traded entity, validating the university-venture capital model. Erin Rothwell, vice president of research at the U, emphasized that the fund represents part of a larger strategic plan to enhance the university's technology transfer process and embed commercialization earlier within research initiatives rather than treating it as an afterthought. The Utah Venture Hub, run by Jim Hotaling in his role as associate vice president of research for commercialization, facilitated the partnership, underscoring the university's institutional commitment to bridging the gap between academic discovery and entrepreneurial execution.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.